NEPH · Nephros Inc · Metrics
Market Cap
$48.54M
Shares
10.86M
NEPH metrics
69 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$4.47
Market cap
$48.54M
Price action
20 metricsPrice change (1W)
+8.1%
Price change (30D)
-3.6%
Price change (3M)
+35.7%
Price change (6M)
+18.9%
Price change (YTD)
-7.4%
Price change (1Y)
+5.9%
Trailing year
Price change (5Y)
-47.6%
52-week high
$5.79
52-week low
$2.78
Change from 52-week high
-21.9%
Change from 52-week low
+62.6%
Annualized volatility
85.9%
Annualized volatility (3M)
76.3%
Beta
1.0
RSI (14D)
57.0
Price vs SMA 50
+14.9%
Price vs SMA 200
+16.0%
Avg volume (3M)
19,948
Relative volume
1.6
Average dollar volume
$80,284
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
10.86M
Valuation
12 metricsP / E (TTM)
28.3
Trailing earnings · reciprocal yield 3.5%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.4×
reciprocal yield 42.2%
P / book
4.1
reciprocal yield 24.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
3.5%
Historical valuation
8 metricsP / E historical average (3Y)
49.5×
reciprocal yield 2.0%
P / E historical average (5Y)
49.5×
reciprocal yield 2.0%
EV / revenue historical average (3Y)
3.6×
reciprocal yield 27.5%
EV / revenue historical average (5Y)
4.2×
reciprocal yield 23.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
61.3%
Operating margin
7.9%
Trailing 12 months
Net margin
8.4%
Gross profit (TTM)
$12.70M
Operating profit (TTM)
$1.64M
Net income (TTM)
$1.74M
Trailing 12 months
Diluted EPS (TTM)
$0.16
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+36.2%
Year over year
Net income growth YoY
+405.1%
Revenue (TTM)
$20.72M
Trailing 12 months
EPS growth YoY
+450.0%
Shares change YoY
+2.8%
Year over year · more shares
Revenue CAGR (3Y)
+23.5%
Revenue CAGR (5Y)
+17.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
14.5%
Return on assets
11.0%
Debt / equity
—
Current ratio
4.1
EBITDA (TTM)
$1.77M
Free cash flow (TTM)
—
Quick ratio
2.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.70M
Total assets
$15.77M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$706,000
Capital expenditures (TTM)
—
R&D (TTM)
$1.45M
SG&A (TTM)
$9.48M
Stock compensation (TTM)
$270,000
R&D / revenue
7.0%
Stock compensation / revenue
1.3%
Ownership (13F)
3 metrics13F filers
33
13F filer change QoQ
+6
Institutional ownership
48.9%
Short interest
3 metricsShort interest
0.4%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
47 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—